この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/1/211 分で読めます
Novo Nordisk Bioindustrials, Inc.; Filing of Food Additive Petition
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing that Novo Nordisk Bioindustrials, Inc., has filed a petition proposing that the food additive regulations be amended to provide for the safe use of aspartic proteinase enzyme preparation produced by pure culture fermentation of a strain of Aspergillus oryzae modified by recombinant deoxyribonucleic acid (DNA) techniques to contain the gene for aspartic proteinase enzyme from Rhizomucor miehei for use in the production of cheese.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →